Please login to the form below
Launch excellence: beyond the six-month mantra
While the first six months are important, the prior 36 months are even more so.
Digital applications are transforming the market access landscape
Optimising product value through digital technology
Key considerations for disease- modifying Parkinson’s disease trials
‘Lessons learnt from Alzheimer’s trials could help in Parkinson’s drug development’
Shoring up the framework
European regulators add a measure of clarity to pharma’s uncertainty around Brexit
-
Shoring up the frameworkEuropean regulators add a measure of clarity to pharma’s uncertainty around Brexit
-
Japanese pharma pulls no punches with post-Brexit UKFirm want reassurance from the UK on its future in science and innovation
-
Brexit: the facts (and the alternative facts)How Brexit affects pharma
-
Brexit: Implications for the pharma industryFrom patents to the EMA, data protection to clinical trials, there's a lot that should be a concern
-
Can UK pharma rise to the post-Brexit challenge?Our dominant and thriving industry is one we should be proud of
-
An exciting outlook for pre-approval access and compassionate useHow to deal with the ethical and practical considerations of the demand for promising new drugs that are in development
Subscribe to our email news alerts
- Senior Medical Copywriter - Highly Awarded Advertising Agency
- £50,000 - £60,000 yearly
- Market Access Director, six figure base salary and £5K joining b...
- Highly competitive salary
- Account Manager, 6 month contract, Healthcare Brand communicatio...
- Highly competitive salary
- Home Based Account Manager, Medical Communications, UK, Pharma/M...
- Highly competitive salary
- Account Director, Healthcare Marketing Creative Agency, Fixed te...
- Highly competitive salary
- Account Manager, Healthcare Marketing Creative Agency, Fixed ter...
- Highly competitive salary
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
- Sanofi's frexalimab shows promise in relapsing forms of MS
- BMS and Janssen’s antithrombotic granted FDA fast track designation
- EMA recommends revoking marketing authorisation for Novartis’ sickle cell disease drug
- Amgen reports positive results for Otezla in psoriatic arthritis
- Supply chain challenges in 2023
- Whitepaper: Closing the gap with compelling healthcare communications
- Pfizer’s antibiotic combination shows promise in treating multi-drug resistant infections
- Supporting the most vulnerable: why pharma should get behind the NHS’ healthcare equity campaign
- Healing the Healers
- The (inevitable) digital transformation of Medical Affairs
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
No results were found
PMHub
An agency called Owen
We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....
Latest intelligence
- Whitepaper: Closing the gap with compelling healthcare communications
- Want to learn how to close the distance between a person’s current health and their healthiest possible self?...
- Healing the Healers
- Because if we do not heal the healers, who is going to heal us?...
- The (inevitable) digital transformation of Medical Affairs
- It’s not a question of ‘if,’ it’s a question of ‘when.’...
